GE HealthCare slides as Q1 profit misses and 2026 guidance is cut on inflation, tariffs and a supplier issue

GE HealthCare Technologies Inc. (GEHC) is down 13.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to a first-quarter profit miss and a reduction to full-year 2026 profitability and free-cash-flow expectations. Management pointed to a resolved Pharmaceutical Diagnostics (PDx) supplier issue and more pronounced inflation (notably memory chips, oil and freight), along with tariff-related pressure, which weighed on margins and outlook.

Details:

Adjusted EPS for the quarter was $0.99 versus a consensus estimate around $1.07, despite revenue of about $5.13 billion (up 7.4% year over year).

Adjusted EBIT margin was 13.5% (down from 15.0% a year ago), with profitability impacted by tariffs, weakness in Patient Care Solutions, and the PDx supplier issue.

Full-year 2026 guidance was trimmed: adjusted EBIT margin to 15.4%–15.7% (from 15.8%–16.1%) and adjusted EPS to $4.80–$5.00 (from $4.95–$5.15).

Free cash flow outlook was reduced to approximately $1.6 billion (from approximately $1.7 billion).

Sources:

U.S. SEC (EDGAR), Business Wire, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive GEHC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$GEHC Hedge Fund Activity

We have seen 496 institutional investors add shares of $GEHC stock to their portfolio, and 625 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AUTO-OWNERS INSURANCE CO removed 33,568,289 shares (-98.8%) from their portfolio in Q1 2026, for an estimated $2,335,010,182
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,676,862 shares (-75.5%) from their portfolio in Q4 2025, for an estimated $629,656,221
BARROW HANLEY MEWHINNEY & STRAUSS LLC added 6,506,398 shares (+inf%) to their portfolio in Q4 2025, for an estimated $533,654,763
HARRIS ASSOCIATES L P added 4,833,318 shares (+43.9%) to their portfolio in Q4 2025, for an estimated $396,428,742
CYNOSURE GROUP, LLC added 4,344,817 shares (+21045.4%) to their portfolio in Q4 2025, for an estimated $356,361,890
DODGE & COX added 3,693,918 shares (+13.4%) to their portfolio in Q4 2025, for an estimated $302,975,154
ALLIANCEBERNSTEIN L.P. removed 2,431,005 shares (-56.5%) from their portfolio in Q4 2025, for an estimated $199,391,030

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$GEHC Congressional Stock Trading

Members of Congress have traded $GEHC stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:

REPRESENTATIVE TERRI A. SEWELL sold up to $15,000 on 03/25.
REPRESENTATIVE WARREN DAVIDSON sold up to $15,000 on 03/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$GEHC Analyst Ratings

Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 01/30/2026
BTIG issued a "Buy" rating on 11/21/2025

To track analyst ratings and price targets for $GEHC, check out Quiver Quantitative's $GEHC forecast page.

$GEHC Price Targets

Multiple analysts have issued price targets for $GEHC recently. We have seen 13 analysts offer price targets for $GEHC in the last 6 months, with a median target of $87.0.

Here are some recent targets:

Ryan Zimmerman from BTIG set a target price of $85.0 on 04/21/2026
Jason Bednar from Piper Sandler set a target price of $88.0 on 04/17/2026
Anthony Petrone from Mizuho set a target price of $90.0 on 04/13/2026
David Roman from Goldman Sachs set a target price of $81.0 on 04/09/2026
Vijay Kumar from Evercore ISI Group set a target price of $85.0 on 04/06/2026
Joanne Wuensch from Citigroup set a target price of $84.0 on 03/11/2026
Matt Miksic from Barclays set a target price of $87.0 on 02/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.